PDS Biotechnology (FRA:EU6) GF Score: 31/100 (As of Jul. 08, 2026) — 11% Below Median


FRA:EU6 PDS Biotechnology Corp FRA:EU6
31 GF Score
Price €0.74
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology GF Score?

PDS Biotechnology FRA:EU6 -1.33% 31 GF Score is 31 as of Jul. 08, 2026, which is 11% below its 10-year median of 35.00. GuruFocus rates FRA:EU6 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

PDS Biotechnology has the GF Score of 31, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 7/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes PDS Biotechnology might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

PDS Biotechnology  (FRA:EU6) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

PDS Biotechnology GF Score Related Terms

FRA:EU6 vs LTRN, AURX, VERU: GF Score Comparison

For the Biotechnology subindustry, PDS Biotechnology's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PDS Biotechnology GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's GF Score distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's GF Score falls into.


FRA:EU6
31GF Score
PDS Biotechnology Corp FRA:EU6
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 31 mean?
PDS Biotechnology (FRA:EU6) has a GF Score of 31 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on PDS Biotechnology and its competitors. This is 11% below median its historical median of 35.00. Over the past decade, PDS Biotechnology's GF Score has ranged from 11.00 to 44.00.
Is PDS Biotechnology's GF Score too high?
PDS Biotechnology's current GF Score of 31 is 11% below median its 10-year median of 35.00. Over the past 10 years, this metric has ranged from a low of 11.00 to a high of 44.00. Overall, PDS Biotechnology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's GF Score compare to LTRN and AURX?
PDS Biotechnology's GF Score of 31 can be compared against companies in the Biotechnology industry. Historically, PDS Biotechnology's own GF Score has ranged from 11.00 to 44.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current GF Score is 31, which is 11% below median its own 10-year median of 35.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current GF Score of 31. The current GF Score is 31, which is 11% below median its 10-year median of 35.00. PDS Biotechnology's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current GF Score is 31 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
31GF Score

Get the complete analysis for FRA:EU6

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.74
Price